Early research (Phase 1)Study completedNCT00009841What this trial is testingGene Therapy in Treating Patients With Advanced Head and Neck CancerWho this might be right forHead and Neck Cancer University of Pittsburgh 13
Not applicableStudy completedNCT04696744What this trial is testingProspective Study for the Prognostic and Predictive Role of Circulating Tumor Cells in Patients With Oropharyngeal Squamous Cell Carcinoma: CTCO (Circulating Tumor Cells in the Oropharynx)Who this might be right forCirculating Tumor CellOropharyngeal Cancer Hospices Civils de Lyon 12
Not applicableLooking for participantsNCT02012699What this trial is testingIntegrated Cancer Repository for Cancer ResearchWho this might be right forPancreatic CancerThyroid CancerLung Cancer+47 more University of Nebraska 999,999
Testing effectiveness (Phase 2)Study completedNCT00003565What this trial is testingDocetaxel in Treating Patients With Solid TumorsWho this might be right forBladder CancerBreast CancerHead and Neck Cancer+2 more Alliance for Clinical Trials in Oncology 109
Early research (Phase 1)Study completedNCT02113878What this trial is testingPhase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and NeckWho this might be right forCarcinoma, Squamous Cell of Head and NeckHPV Positive Oropharyngeal Squamous Cell CarcinomaHypopharyngeal Cancer+3 more Dana-Farber Cancer Institute 23
Testing effectiveness (Phase 2)Study completedNCT02254278What this trial is testingReduced-Dose Intensity-Modulated Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Oropharyngeal CancerWho this might be right forStage III Oropharyngeal Squamous Cell CarcinomaStage IVA Oropharyngeal Squamous Cell CarcinomaStage IVB Oropharyngeal Squamous Cell Carcinoma+2 more NRG Oncology 316
Testing effectiveness (Phase 2)Study completedNCT00425750What this trial is testingBortezomib and Docetaxel in Treating Patients With Recurrent or Metastatic Head and Neck CancerWho this might be right forHead and Neck Cancer Vanderbilt-Ingram Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT00049140What this trial is testingEF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck CancerWho this might be right forHead and Neck Cancer David M. Brizel, MD 8
Testing effectiveness (Phase 2)Study completedNCT00024089What this trial is testingGefitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck CancerWho this might be right forHead and Neck Cancer National Cancer Institute (NCI) 60
Early research (Phase 1)Study completedNCT00004246What this trial is testingRadiation Therapy Plus Fludarabine in Treating Patients With Locally Advanced Cancer of the Mouth, Pharynx, or LarynxWho this might be right forHead and Neck Cancer M.D. Anderson Cancer Center 16
Not applicableStudy completedNCT02072148What this trial is testingThe Sinai Robotic Surgery Trial in HPV Positive Oropharyngeal Squamous Cell Carcinoma (SCCA) (SIRS TRIAL)Who this might be right forHuman Papilloma VirusOropharyngeal Squamous Cell Carcinoma Icahn School of Medicine at Mount Sinai 112
Testing effectiveness (Phase 2)WithdrawnNCT00084435What this trial is testingS0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck CancerWho this might be right forHead and Neck Cancer SWOG Cancer Research Network
Testing effectiveness (Phase 2)Looking for participantsNCT07209189What this trial is testingNeoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)Who this might be right forHead and Neck CancerSquamous Cell CarcinomaOral Cavity Cancer+6 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 75
Not applicableLooking for participantsNCT05522881What this trial is testingThe Registry Study of Genetic Alterations of Oropharyngeal Cancer in TaiwanWho this might be right forOropharyngeal Squamous Cell Carcinoma National Health Research Institutes, Taiwan 410
Testing effectiveness (Phase 2)UnknownNCT00357617What this trial is testingCelecoxib in Treating Patients With Head and Neck Cancer That Can Be Removed By SurgeryWho this might be right forHead and Neck Cancer Centre Hospitalier Universitaire Vaudois 24
Testing effectiveness (Phase 2)Study completedNCT01044433What this trial is testingCapecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and NeckWho this might be right forHead and Neck CancerMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult Primary+17 more Abramson Cancer Center at Penn Medicine 44
Not applicableLooking for participantsNCT06115772What this trial is testingProspective Assessment of HPV Associated Anogenital Pathology in Female Patients and Female Partners of Patients With Confirmed HPV Associated Oropharyngeal Carcinoma, PAP-OP StudyWho this might be right forOropharyngeal Human Papillomavirus-Positive Squamous Cell Carcinoma Mayo Clinic 154
Not applicableStudy completedNCT01015963What this trial is testingStudying DNA in Tissue Samples From Caucasian and African-American Cancer Patients Who Received Docetaxel on Clinical Trial CLB-9871Who this might be right forBladder CancerBreast CancerHead and Neck Cancer+2 more Alliance for Clinical Trials in Oncology 69
Not applicableStudy completedNCT03435471What this trial is testingOutcomes of Prophylactic Swallowing Therapy in Patients Undergoing Definitive Chemoradiation for Head and Neck CancerWho this might be right forHead and Neck CancerOropharynx Cancer University of Miami 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05787639What this trial is testingNeoadjuvant Immunoradiotherapy With Evorpacept and Pembrolizumab in HPVOPC (Human Papilloma Virus Oropharynx Cancer)Who this might be right forOropharynx Cancer University of California, San Diego 28